Correlation Between NEOBO FASTIGHETER and AlzeCure Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NEOBO FASTIGHETER and AlzeCure Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NEOBO FASTIGHETER and AlzeCure Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NEOBO FASTIGHETER and AlzeCure Pharma, you can compare the effects of market volatilities on NEOBO FASTIGHETER and AlzeCure Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NEOBO FASTIGHETER with a short position of AlzeCure Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of NEOBO FASTIGHETER and AlzeCure Pharma.

Diversification Opportunities for NEOBO FASTIGHETER and AlzeCure Pharma

-0.72
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between NEOBO and AlzeCure is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding NEOBO FASTIGHETER and AlzeCure Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AlzeCure Pharma and NEOBO FASTIGHETER is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NEOBO FASTIGHETER are associated (or correlated) with AlzeCure Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AlzeCure Pharma has no effect on the direction of NEOBO FASTIGHETER i.e., NEOBO FASTIGHETER and AlzeCure Pharma go up and down completely randomly.

Pair Corralation between NEOBO FASTIGHETER and AlzeCure Pharma

Assuming the 90 days trading horizon NEOBO FASTIGHETER is expected to generate 0.61 times more return on investment than AlzeCure Pharma. However, NEOBO FASTIGHETER is 1.63 times less risky than AlzeCure Pharma. It trades about 0.14 of its potential returns per unit of risk. AlzeCure Pharma is currently generating about -0.27 per unit of risk. If you would invest  1,572  in NEOBO FASTIGHETER on September 2, 2025 and sell it today you would earn a total of  277.00  from holding NEOBO FASTIGHETER or generate 17.62% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

NEOBO FASTIGHETER  vs.  AlzeCure Pharma

 Performance 
       Timeline  
NEOBO FASTIGHETER 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in NEOBO FASTIGHETER are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, NEOBO FASTIGHETER unveiled solid returns over the last few months and may actually be approaching a breakup point.
AlzeCure Pharma 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days AlzeCure Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2026. The current disturbance may also be a sign of long term up-swing for the company investors.

NEOBO FASTIGHETER and AlzeCure Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NEOBO FASTIGHETER and AlzeCure Pharma

The main advantage of trading using opposite NEOBO FASTIGHETER and AlzeCure Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NEOBO FASTIGHETER position performs unexpectedly, AlzeCure Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AlzeCure Pharma will offset losses from the drop in AlzeCure Pharma's long position.
The idea behind NEOBO FASTIGHETER and AlzeCure Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Fundamental Analysis
View fundamental data based on most recent published financial statements
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments